Observations placeholder
Magnevist
Identifier
019906
Type of Spiritual Experience
Background
A description of the experience
Gadopentetic acid is one of the trade names for a gadolinium-based MRI contrast agent, usually administered as a salt of a complex of gadolinium with DTPA (diethylenetriaminepentacetate) with the chemical formula A2[Gd(DTPA)(H2O)]; when cation A is the protonated form of the amino sugar meglumine the salt goes under the name "gadopentetate dimeglumine". It was described in 1981 and introduced as the first MRI contrast agent in 1987. It is used to assist imaging of blood vessels and of inflamed or diseased tissue where the blood vessels become "leaky". It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood–brain barrier. It is usually injected intravenously.
.
A bottle of Magnevist contrast agent.
Marketed as Magnevist a, it was the first intravenous contrast agent to become available for clinical use, and is in widespread use around the world.
Gadolinium based agents may cause a toxic reaction known as nephrogenic systemic fibrosis (NSF) in patients with severe kidney problems
On Jan, 6, 2016: 9,169 people reported to have side effects when taking Magnevist. Among them, 11 people (0.12%) have Hallucination.
Time on Magnevist when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 6, 2016: 9,169 people reported to have side effects when taking Magnevist. Among them, 53 people (0.58%) have Death.
Time on Magnevist when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 98.31% | 1.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |